Oncolytics Biotech Inc. beat EPS estimates 0% of the time across 1 reported quarters (0 beats, 1 misses). Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result |
|---|---|---|---|---|
| Q12026 FY2026 | $-0.05 | $-0.08 | -60.0% | Miss |
| Q1 FY2026 | $-0.05 | — | — | Miss |
| 2026-03-06 | $-0.06 | — | — | Miss |
Back to ONCY overview · ONCY holders · ONCY KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.